INDAZOLE COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS FOR INHIBITING PROTEIN KINASES, AND METHODS FOR THEIR USE

Indazole compounds that modulate and/or inhibit the activity of certain protein kinases are described. These compounds and pharmaceutical compositions containing them are capable of mediating tyrosine kinase signal transduction and thereby modulate and/or inhibit unwanted cell proliferation. The inv...

Full description

Saved in:
Bibliographic Details
Main Authors JOHNSON MICHAEL DAVID, LUU HIEP THE, JOHNSON THEODORE OTTO, PALMER CYNTHIA LOUISE, BORCHARDT ALLEN J, KANIA ROBERT STEVEN, VARNEY MICHAEL DAVID, BENDER STEVEN LEE, TENG MIN, HUA YE, THOMAS CHRISTINE, REICH SIEGFRIED HEINZ, CRIPPS STEPHAN JAMES, WALLACE MICHAEL BRENNAN, TEMPCZYK-RUSSELL ANNA MARIE, COLLINS MICHAEL RAYMOND
Format Patent
LanguageEnglish
Published 04.11.2004
Edition7
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
METALLURGY
ORGANIC CHEMISTRY
Online AccessGet full text

Cover

More Information
Summary:Indazole compounds that modulate and/or inhibit the activity of certain protein kinases are described. These compounds and pharmaceutical compositions containing them are capable of mediating tyrosine kinase signal transduction and thereby modulate and/or inhibit unwanted cell proliferation. The invention is also directed to the therapeutic or prophylactic use of pharmaceutical compositions containing such compounds, and to methods of treating cancer and other disease states associated with unwanted angiogenesis and/or cellular proliferation, such as diabetic retinopathy, neovascular glaucoma, rheumatoid arthritis, and psoriasis, by administering effective amounts of such compounds.
Bibliography:Application Number: US20030326037